-
Shandong Pharmaceutical Companies Grab Over $1 Billion of Antithrombotic Drugs for The First Imitati...
On May 27, Shandong New Era Pharmaceuticals submitted a generic marketing application for Class 4 edoxaban tosylate tablets.
2022-05-30 17:19 -
Facing Omicron, Where is the Next 'Special Medicine'?
The COVID-19 outbreak started in early 2020 and has not completely disappeared. The new coronavirus is constantly mutating, among which Omicron has be...
2022-05-27 09:20 -
Week 21 Partial Veterinary Drug Quotes 2
Monosulfate kanamycin, the market inquiry is small, the transaction volume is small, the market price is 305, the actual transaction price is negotiab...
2022-05-26 13:52 -
Analysis of The Veterinary Drug Raw Material Market in the 21st Week
Florfenicol, the price has risen steadily, the market has returned to rationality, and the market quotation is above 455
2022-05-26 13:49 -
AstraZeneca's Selumetinib Capsules Received CDE Priority Review
Today, the CDE official website announced that AstraZeneca's Selumetinib Capsules will be included in priority review. Selumetinib is the world's firs...
2022-05-26 13:44 -
Pfizer to Sell All Drugs at Cost in Low-income Countries
On May 25, Pfizer plans to sell all of its drug portfolio at cost in as many as 45 low-income countries. The program, which will initially launch in f...
2022-05-25 18:02 -
Reduced the Risk of Disease Progression by 71% Innovative Anti-cancer Therapy Reached Phase 3 Clinic...
Today, SpringWorks Therapeutics announced that its oral specific gamma-secretase small molecule inhibitor nirogacestat met the primary endpoint in a P...
2022-05-25 11:19 -
Roche's Next-generation C5 Complement Inhibitor Crovalimab Successfully Completed Phase III Study in...
On May 23, Roche announced that its innovative drug crovalimab has achieved positive results in a phase III clinical study (COMMDORE 3) for the treatm...
2022-05-24 10:04 -
EU Approves AstraZeneca's COVID-19 Vaccine Vaxzevria as Adult Booster
On May 23, AstraZeneca said its new crown vaccine Vaxzevria had been approved by the European Medicines Agency (EMA) as a booster vaccine for adults.
2022-05-23 17:46 -
CanSino's New covid-19 Vaccine is Included in the World Health Organization's Emergency Use List
On May 19, 2022, Beijing time, the World Health Organization released information on its official website, officially listing CanSino Bio’s recombina...
2022-05-23 16:57
Hot News
- ExxonMobil Launches $10 Billio... Jul 17, 2025
- Global MDI/TDI Plants Enter Pe... Jul 23, 2025
- Europe Faces Unprecedented Pet... Jul 23, 2025
- Sally Beauty Acquires Flair Ha... Jul 07, 2025
- Guangdong Jieyang Puts into Op... Jul 16, 2025
Related Products
Related Producers
